SCHEMBL9025935

SCHEMBL9025935

CC(Oc1ccc(Cl)cc1)c1nc(-c2ccccc2)c(-c2ccc(S(C)(=O)=O)cc2)o1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.55
FAAH O00519 1/20 0.48
KCNH2 Q12809 1/20 0.48
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PTGS1 P23219 5/20 0.43
RXRA P19793 2/20 0.41
RXRB P28702 2/20 0.41
RXRG P48443 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9026123 1.00 PTGS2 (0.55) PTGS2FAAHKCNH2CYP1A2CYP3A4
SCHEMBL9026297 0.88 PTGS2 (0.53) PTGS2CYP1A2CYP2C19ALDH1A1PTGS1
SCHEMBL9026207 0.80 CYP3A4 (0.41) PTGS2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9037840 0.79 CA1 (0.44) PTGS2CYP3A4CYP2C19ALDH1A1LMNA
SCHEMBL9024861 0.79 PTGS2 (0.66) PTGS2PTGS1RXRA
SCHEMBL7502050 0.78 PTGS2 (0.56) PTGS2FAAHKCNH2CYP1A2CYP3A4
SCHEMBL7498789 0.78 PTGS2 (0.56) PTGS2FAAHKCNH2CYP1A2CYP3A4
SCHEMBL7498544 0.77 PTGS2 (0.67) PTGS2PTGS1
SCHEMBL7498729 0.77 PTGS2 (0.67) PTGS2PTGS1
SCHEMBL9026427 0.77 PTGS2 (0.43) PTGS2CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 EP claimed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 WO claimed